125 related articles for article (PubMed ID: 24344216)
1. Adjuvant interferon in melanoma: is duration of therapy important?
McArthur GA
J Clin Oncol; 2014 Jan; 32(3):171-3. PubMed ID: 24344216
[No Abstract] [Full Text] [Related]
2. Adjuvant high-dose interferon therapy for melanoma: nothing has really changed.
Sanchez-Muñoz A; Navarro-Perez V; Alonso L; Moreno I; Alba E
Melanoma Res; 2014 Oct; 24(5):522-3. PubMed ID: 25185694
[No Abstract] [Full Text] [Related]
3. [Adjuvant interferon therapy in malignant melanoma].
Mohr P
J Dtsch Dermatol Ges; 2007 Jun; 5(6):543-5. PubMed ID: 17537052
[No Abstract] [Full Text] [Related]
4. Adjuvant therapy of cutaneous melanoma.
Ascierto PA; Palmieri G
Lancet; 1999 Jan; 353(9149):328. PubMed ID: 9929057
[No Abstract] [Full Text] [Related]
5. [Adjuvant interferon treatment of melanoma].
Török L
Magy Onkol; 2003; 47(1):105-7. PubMed ID: 12704462
[TBL] [Abstract][Full Text] [Related]
6. How melanoma is treated in real life.
Dummer R; Schadendorf D
Arch Dermatol; 2008 May; 144(5):664-5. PubMed ID: 18490596
[No Abstract] [Full Text] [Related]
7. Do β-blockers slow down melanoma progression?
Lens M
Arch Intern Med; 2011 Oct; 171(18):1686-7; author reply 1687. PubMed ID: 21987205
[No Abstract] [Full Text] [Related]
8. Opioids and dose-related deaths--association or causation?
Williamson OD
Arch Intern Med; 2011 Oct; 171(18):1687-8; author's reply 1688-9. PubMed ID: 21987206
[No Abstract] [Full Text] [Related]
9. Long-term outcomes and prognostic factors of high-risk malignant melanoma patients after surgery and adjuvant high-dose interferon treatment: a single-center experience.
Akman T; Oztop I; Unek IT; Koca D; Unal OU; Salman T; Yavuzsen T; Yilmaz AU; Somali I; Demir N; Ellidokuz H
Chemotherapy; 2014; 60(4):228-38. PubMed ID: 25870939
[TBL] [Abstract][Full Text] [Related]
10. Role functioning before start of adjuvant treatment was an independent prognostic factor for survival and time to failure. A report from the Nordic adjuvant interferon trial for patients with high-risk melanoma.
Brandberg Y; Johansson H; Aamdal S; Bastholt L; Hernberg M; Stierner U; von der Maase H; Hansson J;
Acta Oncol; 2013 Aug; 52(6):1086-93. PubMed ID: 23621752
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant interferon in melanoma - a resurrection?
Middleton MR; Thatcher N
Br J Cancer; 2001 May; 84(9):1141-2. PubMed ID: 11336461
[No Abstract] [Full Text] [Related]
12. Demodex as a Delivery Vector for Topical Targeted Medications in the Skin for Early Melanoma and Non-Melanoma Skin Cancer.
Strobel SL
Ann Clin Lab Sci; 2017 Sep; 47(5):604-605. PubMed ID: 29066489
[TBL] [Abstract][Full Text] [Related]
13. Melanoma research gathers momentum.
Lancet; 2015 Jun; 385(9985):2323. PubMed ID: 26088624
[No Abstract] [Full Text] [Related]
14. The use of interferon alfa as adjuvant therapy for advanced cutaneous melanoma: the need for more evidence.
Kimyai-Asadi A; Usman A
J Am Acad Dermatol; 2000 Oct; 43(4):708-11. PubMed ID: 11004636
[TBL] [Abstract][Full Text] [Related]
15. Is there a standard for the palliative treatment of melanoma?
Schadendorf D
Onkologie; 2002 Feb; 25(1):74-6. PubMed ID: 11928697
[No Abstract] [Full Text] [Related]
16. Duration of high-dose interferon alpha-2b regimen for resected high-risk melanoma.
Agarwala SS; Gray RJ; Wong MK
J Clin Oncol; 2009 Sep; 27(25):e82-3; author reply e84. PubMed ID: 19635995
[No Abstract] [Full Text] [Related]
17. Adjuvant interferon therapy for melanoma: high-dose, low-dose, no dose, which dose?
Schuchter LM
J Clin Oncol; 2004 Jan; 22(1):7-10. PubMed ID: 14665612
[No Abstract] [Full Text] [Related]
18. Adjuvant therapy for malignant melanoma.
Stoutenburg JP; Schrope B; Kaufman HL
Expert Rev Anticancer Ther; 2004 Oct; 4(5):823-35. PubMed ID: 15485316
[TBL] [Abstract][Full Text] [Related]
19. [Ocular complications of adjuvant interferon therapy for malignant melanoma: a review].
Ockenfels M; Lisch W
Hautarzt; 2003 Feb; 54(2):144-7. PubMed ID: 12590309
[TBL] [Abstract][Full Text] [Related]
20. Care of the patient undergoing interferon therapy.
Garvey EC; Matutat RJ; Bolten D
Cancer Nurs; 1983 Aug; 6(4):303-6. PubMed ID: 6192903
[No Abstract] [Full Text] [Related]
[Next] [New Search]